Keyword: Yale University

The partners will study patient-focused endpoints alongside so-called “hard outcomes" that have traditionally served as endpoints in clinical trials.

The partners will use wearable devices to assess how heart failure patients function and feel after being discharged from hospitals.

Yale researchers discovered that AstraZeneca’s anti-VEGF cancer drug cediranib may boost the effectiveness of PARP inhibitors.

A Yale University team found two potential methods for preventing fat particles from slipping into tissues.

The week’s biotech news included a mutation-targeting treatment for ALS and a malaria vaccine targeting a transmission protein.

The mechanism by which PARP inhibitors in BRCA-mutated cancers work could make them applicable to many more cancer types.

A Yale team has developed an alternative gene-editing technology that they say replaces CRISPR’s “hacksaw” effect with a more precise “scalpel.”

Scientists at Yale believe they’ve found an immune connection to the inability to burn belly fat—and a possible solution.

The past week ushered in new discoveries of key cancer gene mutations and the T cells behind autoimmune diseases.

Scientists at Yale University believe they’ve discovered how lysosomes—the "garbage disposal" units in brain cells—contribute to Alzheimer’s.